Moderna, Inc. (MRNA)
59.82
-2.00
(-3.24%)
USD |
NASDAQ |
Jul 20, 15:28
Moderna Price : 59.82 for July 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 17, 2026 | 61.68 | 63.28 | 61.06 | 61.82 | 4.552M |
| Jul 16, 2026 | 67.07 | 67.42 | 62.80 | 63.15 | 5.593M |
| Jul 15, 2026 | 67.79 | 68.49 | 65.95 | 68.28 | 3.428M |
| Jul 14, 2026 | 66.67 | 67.89 | 65.80 | 67.44 | 5.812M |
| Jul 13, 2026 | 66.33 | 69.55 | 65.54 | 67.01 | 8.522M |
| Jul 10, 2026 | 76.72 | 76.72 | 67.31 | 68.27 | 9.177M |
| Jul 09, 2026 | 73.80 | 76.84 | 73.14 | 76.56 | 4.415M |
| Jul 08, 2026 | 77.34 | 78.30 | 73.34 | 73.80 | 6.582M |
| Jul 07, 2026 | 82.10 | 82.90 | 77.41 | 79.77 | 8.688M |
| Jul 06, 2026 | 78.55 | 85.60 | 77.50 | 81.80 | 17.30M |
| Jul 02, 2026 | 73.71 | 81.40 | 73.68 | 79.76 | 14.11M |
| Jul 01, 2026 | 70.04 | 73.91 | 68.87 | 72.50 | 9.275M |
| Jun 30, 2026 | 69.84 | 73.28 | 69.22 | 70.03 | 11.81M |
| Jun 29, 2026 | 67.94 | 69.90 | 66.30 | 69.70 | 8.077M |
| Jun 26, 2026 | 59.46 | 69.28 | 59.23 | 67.27 | 14.46M |
| Jun 25, 2026 | 60.33 | 61.86 | 57.91 | 59.75 | 6.799M |
| Jun 24, 2026 | 61.17 | 62.75 | 59.85 | 60.42 | 11.70M |
| Jun 23, 2026 | 59.05 | 63.98 | 58.34 | 61.00 | 6.814M |
| Jun 22, 2026 | 64.07 | 65.51 | 57.50 | 59.34 | 8.363M |
| Jun 18, 2026 | 63.96 | 67.74 | 60.73 | 63.96 | 24.08M |
| Jun 17, 2026 | 56.21 | 62.30 | 54.51 | 61.80 | 12.45M |
| Jun 16, 2026 | 52.24 | 57.79 | 51.66 | 55.40 | 13.05M |
| Jun 15, 2026 | 51.37 | 52.23 | 49.84 | 52.13 | 6.342M |
| Jun 12, 2026 | 49.98 | 51.75 | 49.62 | 49.91 | 5.081M |
| Jun 11, 2026 | 46.43 | 49.94 | 46.30 | 49.64 | 6.196M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioNTech SE | 91.73 |
| Kailera Therapeutics, Inc. | 18.01 |
| Replimune Group, Inc. | 10.47 |
| Sarepta Therapeutics, Inc. | 16.99 |
| Erasca, Inc. | 19.16 |
Price Related Metrics
| PS Ratio | 10.52 |
| Price to Book Value | 3.206 |
| Earnings Yield | -13.62% |
| Market Cap | 23.75B |